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Sustained MAPK/ERK Activation in Adult Schwann Cells
Impairs Nerve Repair
XIlaria Cervellini,1 Jorge Galino,1Ning Zhu,1 XShannen Allen,1 XCarmen Birchmeier,2 and XDavid L. Bennett1
1The Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom, and 2Developmental
Biology/Signal Transduction Group, Max Delbru¨ck Center for Molecular Medicine (MDC) in the Helmholtz Society, 13125 Berlin, Germany
The MAPK/ERK pathway has a critical role in PNS development. It is required for Schwann cell (SC) differentiation and myelination;
sustained embryonic MAPK/ERK activation in SCs enhances myelin growth overcoming signals that normally end myelination. Excess
activation of this pathway can be maladaptive as in adulthood acute strong activation of MAPK/ERK has been shown to cause SC
dedifferentiation and demyelination. We used a mouse model (including male and female animals) in which the gain-of-function
MEK1DD allele produces sustainedMAPK/ERK activation in adult SCs, andwe determined the impact of such activation on nerve repair.
In the uninjured nerve,MAPK/ERK activation neither impairedmyelin nor reactivatedmyelination. However, in the injured nerve it was
detrimental and resulted in delayed repair and functional recovery. In the early phase of injury, the rate of myelin clearance was faster.
Fourweeks following injury, when nerve repair is normally advanced,myelinated axons ofMEK1DDmutants demonstrated higher rates
ofmyelin decompaction, a reduced number of Cajal bands. and decreased internodal length.We noted the presence of abnormal Remak
bundles with long SCs processes and reduced numbers of C-fibers/Remak bundle. Both the total number of regenerating axons and the
intraepidermal nerve fiber density in the skin were reduced. Sustained activation of MAPK/ERK in adult SCs is therefore deleterious to
successful nerve repair, emphasizing the differences in the signaling processes coordinating nerve development and repair. Our results
also underline the key role of SCs in axon regeneration and successful target reinnervation.
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Introduction
Peripheral nerve regeneration after injury is a complex process
requiring signaling among injured axons, Schwann cells (SCs),
and immune cells. During regeneration, a repair program is in-
duced in myelinating and nonmyelinating SCs that supports re-
generation (Arthur-Farraj et al., 2012; Jessen and Mirsky, 2016).
The first phase of the injury response is Wallerian degeneration
(WD), which involves axon destruction, dedifferentiation of SCs,
activation of an inflammatory response, and phagocytosis of my-
elin debris (Chen et al., 2007; Jessen andMirsky, 2016). Schwann
cells start to proliferate, downregulate myelin gene expression,
and adopt a repair phenotype. Subsequently, repair SCs dif-
ferentiate again intomature SCs to generatemyelin-forming and
non-myelin-forming (Remak) cells (Arthur-Farraj et al., 2012).
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Significance Statement
The MAPK/ERK pathway promotes developmental myelination and its sustained activation in SCs induced continuous myelin
growth, compensating for the absenceof essentialmyelination signals.However, the strengthof activation is fundamental because
acute strong induction of MAPK/ERK in adulthood induces demyelination. What has been unknown is the effect of a mild but
sustainedMAPK/ERK activation in SCs on nerve repair in adulthood. This promotedmyelin clearance but led to abnormalities in
nonmyelinating and myelinating SCs in the later phases of nerve repair, resulting in slowed axon regeneration, cutaneous rein-
nervation, and functional recovery. Our results emphasize the distinct role of the MAPK/ERK pathway in developmental myeli-
nation versus remyelination and the importance of signaling between SCs and axons for successful axon regeneration.
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Although regeneration happens spontaneously in the peripheral
nervous system (PNS), unfortunately, it is imperfect: large-diameter
axons are remyelinated, but such myelin is thinner compared with
the naive state (Schro¨der, 1972); target reinnervation occurs but can
be slow and misdirected; and, as a consequence, functional out-
comes in patients are often poor (Palispis and Gupta, 2017).
Mitogen-activated protein kinase (MAPK) is a signal trans-
duction pathway involved in many physiological processes such
as gene expression, metabolism, survival, proliferation, and cell
differentiation (Cargnello and Roux, 2011; Pearson et al., 2001).
This family of kinases is regulated by a phosphorylation cascade
and requires an extracellular stimulus for activation. The ERK1/2
cascade was the first MAPK pathway described (Seger and Krebs,
1995) in which phosphorylation of ERK1/2 by the MAPK kinase
1 (MEK1) activates MAPK signaling. The role of this pathway in
developmental myelination both in the CNS and PNS has been
widely investigated. InCNS, ERK1/2 has been shown to be critical
for myelination during development (Ishii et al., 2012) and for
myelin maintenance (Ishii et al., 2014). In the PNS, the ablation
of ERK1/2 in SCs arrested their differentiation, resulting in dra-
matic hypomyelination and suggesting a positive role of ERK1/2
in the regulation ofmyelination (Newbern et al., 2011; Ishii et al.,
2014). When sustained MAPK/ERK activation was induced in SCs
during embryonic development, this resulted in increased myelin
thickness (Ishii et al., 2012; Sheean et al., 2014) due to continuous
myelin growth. Such sustained MAPK/ERK activation was able to
replace the ablationof essentialmyelinating genes suchasErbB3and
Shp2 (Sheean et al., 2014).
It is known that after nerve injury ERK1/2 signaling is rapidly
activated and contributes to SC dedifferentiation phenotype of
WD (Sheu et al., 2000; Harrisingh et al., 2004). Napoli et al. (2012)
demonstrated that a rapid and transient ERK1/2 activation in SCs
in the absence of axonal injury was sufficient to induce demyeli-
nation and recruitment of inflammatory cells and was followed
by remyelination as ERK1/2 levels normalized. The strength and
temporal profile of MAPK/ERK induction is a key factor in the
regulation of the signaling pathway, and our aim was to use a
mutant mouse expressing a MEK1DD gain-of-function allele in
SCs, which has been shown to promote developmental myelina-
tion, to determine whether sustained MAPK/ERK activation in
adult SCs could enhance myelin production and nerve repair
(Sheean et al., 2014).
By using this model, we observed that this MAPK/ERK acti-
vation did not have any effect onmyelin stability in the naive state
up to 6 weeks. After nerve crush, mutant mice showed signs of
more rapid clearance of myelin debris. However, at later stages of
the injury response, functional recovery was delayed with mor-
phological defects in both myelinated and nonmyelinated fibers
and a reduced number of regenerating axons. MAPK/ERK acti-
vation decreased myelin stability and reduced internodal length
during regenerationwithout affectingmyelin thickness. Inunmyeli-
nated fibers, it resulted inelongatedSCsprocesses, abnormalRemak
bundle formation, loss of axons, and decreased small-fiber regen-
eration. Together, these results show that the MAPK/ERK path-
way has distinct roles in development and after injury and that
enhanced activation of this pathway during regeneration has a
negative impact on nerve repair.
Materials andMethods
Transgenic animals
All work performed was conform to UKHome Office legislation (Scien-
tific Procedure Act 1986). PLPCre-ERT2;MEK1DDfl/flmice were bred by
crossing PLPCre-ERT2 mice (The Jackson Laboratory) with R26StopFL
MEK1DDfl/fl mice (provided by K. Rajewsky, generated at the Boston
Children’s Hospital, Boston, MA); both colonies were on a C57BL/6
background. Generation of PLPCre-ERT2 mice has been previously de-
scribed (Doerflinger et al., 2003) to obtain an inducible, site-specific
recombination under transcriptional control of the myelin proteolipid
protein gene (Plp) expressed in oligodendrocytes and SCs.Mice homozy-
gous for the R26StopFLMEK1DD conditional allele contain a loxP-
flankedNeo-STOP cassette (for details, see Srinivasan et al., 2009; Sheean
et al., 2014). In PLPCre-ERT2;MEK1DDfl/fl transgenic mice, Cre-
mediated excision of the STOP cassette leads to the expression of
activeMEK1DD signaling molecule in Plp-expressing cells. Conditional
MEK1DDmice were generated by the administration of tamoxifen (0.25
mg/g body weight in corn oil; catalog #T5648, Sigma-Aldrich) by oral
gavage for 5 consecutive days to PLPCre-ERT2;MEK1DDfl/fl mice that
were 8 weeks of age. Littermate PLPCre-negative mice were used as con-
trols. Wherever possible, an equal number of animals of each gender was
used in the experimental groups.
Immunoblotting
Sciatic nerves were homogenized in NP-40 lysis buffer and protein con-
centration was determined using a BCA Protein Assay Kit (Thermo
Fisher Scientific). Proteins (20–40 g) were mixed with SDS gel sample
buffer, electrophoresed in SDS-PAGE precasted gels (Bio-Rad), trans-
ferred to membranes, blocked for 30 min with 5% BSA in TBS-T; and
were immunoblotted with antibodies against Rb phosphorylated (p)-
ERK (1:5000; Cell Signaling Technology), p-AKT (1:1000; Cell Signaling
Technology), ERK1/2 (1:5000; Cell Signaling Technology), Rat myelin
basic protein (MBP; 1:300; Abcam), Rb dystrophin-related protein 2
(DRP2; 1:3000), and Rb periaxin N terminal (1:20,000), both of which
were donatedby theBrophy laboratory (University of Edinburgh,UK).Rb
calnexinwas used as a control (1:1000; Enzo Life Sciences). Second antibod-
ies were ECL anti-Rabbit IgG (GE Healthcare) and polyclonal Rb anti-Rat
Igs/HRP (DAKO). ECL prime Western blotting detection system (GE
Healthcare) was used to detect the immunoreactive bands on chemolumi-
nescence films. Tomeasure signal intensities ImageJ was used.
Immunofluorescence microscopy
Micewere deeply anesthetizedwith pentobarbital and transcardially per-
fused with 5 ml of saline followed by 10 ml of paraformaldehyde [PFA;
4% in 0.1% phosphate buffer (PB)]. Tissues were cut on a cryostat and
sections blocked using 5% BSA/5% donkey serum in PBS/0.2% Triton
X-100 and 0.1% sodium azide. All primary antibodies were incubated
overnight and secondary for 2 h. Immunofluorescence was visualized
under a Zeiss Imager Z1 microscope. Photographs were taken using an
Axio Camera (Zeiss). Skin biopsy samples were taken from the hindpaw
glabrous skin proximal to the last nodule and were postfixed in PFA 4%
for 30 min, then were transferred to 20% sucrose overnight (4°C), suc-
cessively blocked inOCT embedding compound on dry ice, and stored at
80°C. Transverse sections were cut on a cryostat at the thickness of
14 m onto gelatin-coated Super Frost Ultra Plus slides. C-fibers in the
epidermis were visualized by immunostaining with polyclonal rabbit
PGP 9.5 (1:200; Zytomed). Secondary antibody used was anti-rabbit Cy3
(1:1000; Stratech Scientific). Epidermal fibers were counted at a 63
magnification live on the microscope according to the rules set out by
Lauria (2005). Four sections per animal were counted with the analyst
blind to genotype. The length of the epidermis was measured by ImageJ
in images takenwith 20magnification, andused to calculate the density of
intraepidermal fibers [intraepidermal nerve fiber density (IENFD)] as fibers
permillimeter. Gastrocnemiusmuscles were postfixed for 2 h in PFA 4%
and transferred to 20% sucrose overnight (4°C). Sections were cut at a
thickness of 100 m, put into a 24-well plate, and stored in PBS/0.1%
sodium azide. Floating staining was performed using mouse anti-2H3
(1:200; Developmental Studies Hybridoma Bank), monoclonal mouse
anti-SV2 (1:200; Developmental Studies Hybridoma Bank). The follow-
ing secondary antibodies used: Alexa Fluor 546 goat anti-rat IgG (Life
Technologies) and -bungarotoxin tetramethylrodamine conjugate
(Invitrogen). About 50 muscle terminals were analyzed per mouse.
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Nerve teasing
Sciatic nerves were fixed in 4% PFA/0.1 M PB for 30 min and stored in
PBS/0.1% sodium azide. Nerves were stained with 0.5% osmium tetrox-
ide for 1 h followed by 3 washes of 5 min each with 25% EtOH, 50%
EtOH, and 75% EtOH. Nerves were stored in 50% glycerol and 50% of
70% EtOH and teased in glycerol. Images were taken with the Axio
Camera of the Zeiss Imager Z1 microscope. Internodal distance was
quantified using ImageJ;50 fibers per nerve were analyzed.
Electron microscopy
Distal sciatic nerves were postfixed with 4% PFA and 3% glutaraldehyde
in 0.1 M phosphate buffer. Nerves were osmicated with 1.5% osmium/0.2 M
PB for 90 min, dehydrated and embedded in epoxy resin (embedding
materials, TAAB). Ultrathin sections (90 nm) were cut using a Diatome
diamond knife on the LeicaUC7Ultramicrotome andmounted onto 100
mesh Cu grids coated with formvar. Sections were poststained for 5 min
with lead citrate. Pictures were taken with a Thermo Fisher Scientific
Tecnai T12 Transmission ElectronMicroscope (TEM) at the SirWilliam
Dunn School of Pathology Bioimaging Facility (University of Oxford,
Oxford, UK). For analysis of axons and macrophages, photographs of
randomly chosen entire grid squares were taken, the area of which cov-
ered20% of the total area of the cross section of the sciatic nerve. The
axon count was normalized for the area in squaremillimeters (uninjured
nerves and 5 d postinjury nerves) or for the total nerve area calculated in
semithin sections of the same sciatic nerve (1 month after injury nerves).
Analysis was performed using AxioVision LE software, release 4.2
(Zeiss).
Behavioral tests
All behavioral testing was performed with the observer blind to the ge-
notype of the animal.
Beam test. Proprioception was assessed using a 1m long wooden beam
inwhichmice were recordedmeanwhile walking from a side to the other.
Percentage of incorrect steps were counted successively as ratio between
themean of slips and hops and the total number of stepsmicewere taking
during each run.
Rotarod.Mice were placed on the rotarod (Jones and Roberts, 1968) as
it was rotating at 20 rpm. The time each mouse spent on the rod was
measured, with a cutoff time of 7 min. The test was performed twice for
each animal with an interval of at least 15 min between each test.
Toe-spreading reflex.Motor–muscular function was assessed by gently
liftingmice by the tail in order for them to extend legs laterally and spread
the digits. Toe-spreading reflex of ipsilateral paw was compared with the
contralateral and graded from 0 to 2, as follows: 0, no spreading; 1, interme-
diate spreading; 2 normal spreading. Appearance of this reflex results from
reinnervation of small muscles in the foot.
Pinprick test. Sciatic nerve reinnervation of the skin was assessed
pinching the injured side with a fine insect needle (Fine Science Tools) in
specific parts of paw and toes. Score was given from 0 to 2, as follows:
0, nonreflex withdrawal response; 1, mild reflex; 2, normal reflex.
Figure 1. MAPK/ERK activation in adult Schwann cells does not affect myelin and axons stability. A, Immunoblotting of p-ERK, p-Akt, and ERK1/2 proteins in contralateral nerves 6 weeks after
tamoxifen dosing in sciatic nerves of MEK1DD mutant mice (MEK ) compared with controls (Ctr) mice. Data were normalized vs Calnexin. B, TEM micrographs of uninjured sciatic nerve 6 weeks
post-tamoxifen dosing. C, Summary of themain parameters analyzed to studymyelination and axon survival. Data are reported as percentages ofmyelinated and nonmyelinated axons normalized
for the area in squaremillimeters. The g-ratio of individual fibers in relation to their axon diameter is shown in the scatter plot inD. E, Quantification of IENFD/millimeter from uninjured skin biopsy
specimens. F, Internodal distancemeasured in teased fibers of sciatic nerve.G, Percentage of innervatedNMJs in uninjured nerves. For all analyses, three to fourmice per groupwere analyzed. Scale
bar, 5m. *p 0.05, two-tailed unpaired t test. Error bars indicate SEM.
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Experimental design and statistical analysis
All statistical analysis has been performed using GraphPad Prism 6 Soft-
ware. Data were reported as the mean SEM, and the number of repli-
cates was indicated in each figure legend. The level of significance was set
at p 0.05. The two-tailed unpaired Student’s t test was used to analyze
differences between two groups. To assess statistical differences in behav-
ior experiments with multiple time points repeated-measures two-way
ANOVA was performed with Sidak’s multiple-comparison tests. Distri-
bution plots have been performedwith the SPSS software (IBM), and the
Kolmogorov–Smirnov test has been used for statistical analysis. Statisti-
cal analysis for each panel is specified in the figure legend.
Results
MAPK/ERK activation, as a consequence ofMEK1DD
expression in adult Schwann cells, does not affect myelination
in uninjured nerve over a 6 week time course
We used mice homozygous for the conditional MEK1DD gain
of function allele (MEK1DDfl/fl) that have been crossed with
PLPCre-ERT2 mice, in which the induction of Cre recombinase
activity in the PNS occurs specifically in SCs after tamoxifen
treatment. PLPCre-ERT2;MEK1DDfl/fl adult mice (subsequently
termed MEK1DD mutant), and MEK1DDfl/fl littermates (con-
trols) were dosed with tamoxifen for 1 week. Two weeks later, we
performed nerve crush injury in the left sciatic nerve, and tissue
was harvested at up to 4weeks after injury. Tissues taken from the
contralateral side to the injury (this included sciatic nerve, plan-
tar paw skin, and gastrocnemius muscle) were used to assess the
impact of MAPK/ERK signaling on uninjured peripheral nerve.
At 6 weeks post-tamoxifen dosing, p-ERK protein expression
in the uninjured nerve was significantly increased in mutants
compared with controls, showing thatMAPK/ERK signaling had
been activated (Fig. 1A; control, 1 0.37, vsMEK1DDmutants,
5.45  1.5; p  0.04). No difference was found in the total
ERK1/2 protein expression (Fig. 1A; control, 1  0.5, vs
MEK1DDmutants, 1 0.05). The two groups were also compa-
rable in the expression of p-Akt (control, 1  0.2, vs MEK1DD
mutants, 1.3 0.03) confirming the specificity of p-ERK induc-
tion. Using ultrastructural analysis, we did not find any differ-
ences in myelinated or nonmyelinated axon number, size, or
morphology when comparing the two groups 6 weeks after dos-
ing (Fig. 1B,C). There was no significant difference in the g-ratio
distribution per axon diameter (Fig. 1D). The number of small
fibers counted in paw skin biopsy specimens (Fig. 1E; controls,
40.84  2.2, vs MEK1DD mutants, 34.6  1.9), internodal dis-
tance measured in sciatic teased fibers (Fig. 1F; controls, 540.5
36.98, vs MEK1DD mutants, 584.7  18.5) and neuromuscular
junction (NMJ) innervation were unchanged (Fig. 1G; fully inner-
vated: controls, 73.06  1.9, vs MEK1DD mutants, 73.57  4.1;
partially innervated: controls, 26.94 0.37, vsMek1DDmutants,
26.43  0.37). Thus, activation of the MAPK/ERK in young
Figure 2. Wallerian degeneration is faster inmutantmice after p-ERK induction. A, Electronmicrographs of ipsilateral sciatic nerve sections 5 d postinjury. Arrows indicate intactmyelin sheaths
that are quantified inB. C, Macrophage count in TEM pictures reported as the number ofmacrophages per squaremillimeter.D, Western blot analysis of MBP expression inMEK1DDmutants (MEK )
compared with controls (Ctr). Calnexin was used as a control. n 3 mice/group. Scale bar, 10m. *p 0.05, ***p 0.001, two-tailed unpaired t test. Error bars indicate SEM.
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Mek1DD mutants prolongs developmental myelination, but
MAPK/ERK activation in the adult does not suffice to reinitiate
myelination.
Wallerian degeneration is accelerated byMAPK/ERK
activation
MEK1DDmutants and control littermates mice were dosed for a
week with tamoxifen to activate the MAPK/ERK pathway, and
after 2 weeks sciatic nerve crush was performed. Mice were sac-
rificed 5 d postinjury, and ipsilateral sciatic nerves were analyzed.
As showed by TEM analysis, in both control and mutant nerves
there were clear features of WD with collapsed myelin, resulting
in myelin ovoid formation (Fig. 2A). However, myelin breakdown
was faster in mutant nerves, as confirmed by a significant
decrease in the percentage of intact myelin sheaths in relation to
Figure 3. Slower recovery in MEK1DD mutant mice vs controls, 1 month postinjury. A, Beam test was used to assess balance and motor coordination after injury. B, C, Rotarod test (B) and
toe-spreading reflex test (C) confirmeddeficits inmotor function inMEK1DDmutantmice.C, Representative photographs of the toe spreading fromday13postinjury are shown.D, Pin-prick testwas
used to analyze recovery in sensory functions. n 11mice. All tests were analyzedwith two-way repeated-measures ANOVA; Sidak’smultiple-comparison test apart from the rotarod test inwhich
two-tailed unpaired t test was used. *p 0.05, **p 0.005, ***p 0.001. Error bars indicate SEM.
Table 1. MAPK/ERK activation does not affect myelination during regeneration but
does affect nonmyelinated fiber survival and C-fiber organization in Remak
bundles
Controls MEK1DDmutants p value (t test)
G-ratio 0.66 0.64 0.501
Myelinated axon/nerve 3435.9 2872.7 0.202
Nonmyelinated axon/nerve 8032.6 6129.2 0.023
Aberrant myelinated axon/nerve 293.9 599.9 0.026
Total axon number/nerve 11762.4 9601.9 0.048
C-fibers/RB 5.4 2.8 0.001
The numbers of nonmyelinated fibers and total axons are decreased in mutant mice, whereas no significant differ-
ences between the two groups are observed for the numbers of myelinated fibers. Aberrant myelinated fibers
(presenting with recurrent loops, outfoldings, and myelin decompaction) are increased in mutants. The number of
C-fibers/Remak bundles (RBs) shows a dramatic decrease followingMAPK activation due to a lack of normal Remak
bundle formation. The axon count was normalized for the total nerve area calculated in semithin sections of the
same sciatic nerve. n 3–4 mice/group. Numbers in italics indicate a significant difference between the two
groups; two-tailed unpaired t test.
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the total number of myelinated axons (Fig. 2B; controls, 28.61
1.81, vs MEK1DD mutants, 17.31  3.45; p  0.015). An accel-
eration of WD in mutants was also supported by a significant
increase in the number of macrophages per square millimeter
(Fig. 2C; controls, 1270.83  90.81, vs MEK1DD mutants,
2416.67 265.98; p 0.0003), as assessed by TEM analysis, and
a 2.4-fold decrease in MBP expression (Fig. 2D; controls, 1 
0.15, vsMEK1DDmutants, 0.41 0.12, p 0.037). To conclude
that MAPK/ERK activation in MEK1DD mutants at the time of
injury acceleratesWD, increasing the number of degenerated axons
andmacrophage recruitment and decreasingMBP expression.
Activation of MAPK/ERK results in impaired functional
recovery after injury
To assess the functional consequences of MAPK/ERK activation
in regeneration, we assessed behavioral measures of motor and
sensory function inmice for 1month after nerve crush. Therewas
no difference in baseline (preinjury) values comparingMEK1DD
mutants and littermate controls. MEK1DD mutants showed an
impaired recovery in motor coordination and balance, as as-
sessed by the beam test, that were significantly slower at days 13
and 17 postinjury and still significantly different from controls at
day 32, the end point of the experiment (Fig. 3A). Furthermore,
the rotarod test confirmed decreased motor performance in mu-
tantmice 1month after injury (Fig. 3B; controls, 136.7 47.38 s,
vsMEK1DDmutants, 27.50 13.92 s; p 0.048). Distal senso-
rimotor function was assessed by the toe-spreading reflex test.
This showed a significant slowing in the recovery of toe spreading
in MEK1DD mutants, as shown in the representative photo-
graphs from day 13 postinjury. By day 25 postinjury, the reflex in
the two groupswas comparable. Sensory functionwas assessed by
pin-prick test, and mutant mice actually showed a hypersensitiv-
ity to pin-prick at days 21 and 25 postinjury, but at day 32 postin-
jury the difference was no longer statistically significant (Fig. 3E).
In summary, MEK1DD mutant mice showed impaired recovery
of motor coordination, balance, and a hypersensitivity to pin-
prick post-nerve injury.
MAPK/ERK activation results in morphological
abnormalities in myelinated fibers during regeneration
Given the differences in sensorimotor behavior inMEK1DDmu-
tants versus controls, we undertookmorphological assessment in
Figure 4. MAPK/ERK activation in Schwann cells does not affect myelin thickness, but does affect myelin stability. A–C, Morphological analysis of MEK1DD mutant vs control sciatic nerve at
4 weeks postinjury was undertaken to determine the following: frequency distribution of g-ratio (A); frequency distribution of axon diameter (B); distribution graph of g-ratio in relation to axon
diameter (C).D, TEM pictures of ipsilateral sciatic nerves from control andMEK1DDmutantmice, which illustrate that althoughmyelin thickness does not change there aremyelin defects shown in
E: asterisks illustrate axons with myelin decompaction; arrows point to invaginating recurrent loops; arrowheads indicate supernumerary SC processes surrounding a myelinated axon with poorly
compacted myelin that have the appearance of an early “onion bulb” structure. Error bars indicate SEM. n 3 mice/group. Scale bars: D, 10m; E, top left, 5m; E, all other panels, 2m.
Kolmogorov–Smirnov test performed.
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ipsilateral sciatic nerve of control andmutant mice 1month after
injury. As showed in Table 1, no difference was found in total
g-ratiomeasurement between the two groups, and the analysis of
the g-ratio frequency of distribution confirmed this result (Fig.
4A–C). However, the distribution of the diameters of myelinated
axons showed a significant shift, and smaller myelinated axons
were present in greater frequency in mutants than in control
animals (Fig. 4B; p 0.02, Kolmogorov–Smirnov test). This was
not due to the myelination of small axons that would not
normally be myelinated, because the number of myelinated
axons with1 m diameter between the groups was not differ-
ent (controls, 0.33  0.7%, vs MEK1DD mutants, 1.35 0.6%;
p 0.08). Although MAPK/ERK activation did not alter myelin
thickness, it didhaveadetrimental effectonmyelincompactionand
structure. We defined these myelin defects as myelinated axons
showing the following: recurrent loops, infoldings, and myelin de-
compaction (Fig. 4E) as described by Goebbels et al. (2012). Table 1
reports the significant increase in the frequency of aberrant my-
elinated axons per nerve that was almost twice as high inmutants
as in controls. We also analyzed macrophage number in ipsilat-
eral nerves at the end point of the experiment to check whether
the activation of MAPK/ERK pathway could cause a chronic
macrophage infiltration.However, we did not find any difference
on their number between control and mutant mice (controls,
1475 145.2 macrophages/mm2, vsMEK1DDmutants, 1556
141.2 macrophages/mm2; p 0.15). In addition, after injury we
observed an increase in the area of mutant nerves compared with
the controls (controls, 0.17 0.011 mm2, vsMEK1DDmutants,
0.23  0.014 mm2; p  0.02) and a reduced axonal packing. In
Figure5. Cajal banddisruptionandDRP2 impairment inmutant ipsilateral nerves after injury.A, TEMpictures showinga lackof appositionsbetweenSCplasmamembraneand theabaxonal layer
of themyelin sheath inmutantmice. Scale bars: 2m; insert, 1m. Asterisk shows Cajal bands location; arrow points to the apposition.B, Quantification. C, Periaxin and DRP2were quantified by
Western blot 1 month after injury in sciatic nerves ofMEK1DDmutant mice (MEK ) compared with control (Ctr) mice; calnexin was used as a loading control. D, Teased fibers from ipsilateral sciatic
nerves showeddecreased internodal distance inmutantmice.n3mice/group. *p0.05, ***p0.001, two-tailedunpaired t test. Holm–Sidak testwas performed inB. Error bars indicate SEM.
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addition, a significant reduction in the to-
tal number of axons per nerve was ob-
served (Table 1).
A further dramatic effect of Mek1 in-
duction in remyelinating SCs was the
formation of Cajal bands in regenerated
myelinated fibers. In control mice (Fig.
5A), the abaxonal surface of the myelin
sheath apposes and adheres with the SC
plasma membrane forming the so-called
appositions that flank cytoplasmic chan-
nels known as Cajal bands (Court et al.,
2004). However, mutantmice presented a
loss of appositions (Fig. 5A, arrows in the
insert) with consequent disruption of
Cajal band formation (Fig. 5A, asterisk in
control mice). Quantification showed a
significant increase in the number of my-
elinated axons with no or only one appo-
sition and a significant decrease of axons
with three appositions in MEK1DD mu-
tant mice versus controls (Fig. 5B). No
differences in Cajal bands were found in
contralateral nerves (data not shown). It
is known that appositions contain com-
plexes formed by DRP2, periaxin, and
dystroglycan (Gillespie et al., 1994), with
DRP2 considered a marker for these ap-
positions. In MEK1DD mutant mice, the
expression of DRP2 was significantly de-
creased, as assessed by Western blot analysis
(Fig. 5C; controls, 1 0.2, vsMEK1DDmu-
tants, 0.450.09;p0.017),while periaxin
protein expression did not differ (Fig. 5C;
controls, 1 0.13, vsMEK1DDmutants,
1.15 0.16). Furthermore, elongation of
SCs was compromised in mutants after
injury, as seen by decreased internodal
distance measured in ipsilateral teased fi-
bers (Fig. 5D; controls, 280.2 0.87 m,
vs MEK1DD mutants, 253.8  0.39 m;
p 0.036).
These results suggest that MAPK/ERK activation during re-
generation did not promote remyelination as the g-ratio was
unchanged. Instead, it led to a higher rate of axons with myelin
defects. Furthermore, MAPK/ERK activation in myelinating SCs
resulted in the reduced number of Cajal bands and shortened inter-
nodaldistances.Despite these structural changes inmyelinatingSCs,
motoneurons still reinnervate their targets at 4 weeks after injury,
as assessed by quantification of gastrocnemius muscle innerva-
tion, which was not significantly different in controls and mu-
tants (Fig. 6; fully innervated neuromuscular junctions: control
mice, 87.46 3.4%;MEK1DDmutants, 82.57 1.1%; partially
innervated neuromuscular junctions: controls, 13.83 2.3%, vs
MEK1DDmutants, 17.42 1.1%).
MAPK/ERK activation impairs Remak bundle formation and
unmyelinated axon regeneration after injury
Interestingly, we found that regeneration of small-diameter ax-
ons wasmore dramatically affected byMAPK/ERK activation. As
shown in Table 1, the number of nonmyelinated axons 2 mm
distal to a nerve crush was significantly decreased at 4 weeks
postinjury inMEK1DDmutants compared with controls. Inmu-
tant nerves following injury, we noted the abnormalities of non-
myelinating SCs. There were supernumerary SCs surrounding
myelinated axons (Fig. 7A, arrowheads). Furthermore, inmutant
nerves the morphology of the Remak bundles was altered. Spe-
cifically, the SCs demonstrated longer processes and the number
of C-fibers per Remak bundle was significantly reduced (Table 1,
Fig. 7A).
We also analyzed reinnervation of the skin, the targets of small-
diameter fibers. We collected skin biopsy specimens 3 weeks after
injury from the paws ofmutantmice, and we stained themwith the
axonal marker PGP9.5 to measure intraepidermal nerve fiber
density. Skin ipsilateral to injury inmutant mice showed a signif-
icant decrease in intraepidermal nerve fiber density compared
with skin ipsilateral to injury in controls, which is consistent with
impaired target reinnervation by sensory fibers (Fig. 7B; controls,
7.47 0.0001, vsMEK1DDmutants, 3.52 0.0005; p 0.017).
Discussion
We have used a mouse model in which sustained MAPK/ERK
activation was induced in adult SCs (i.e., after developmental
myelinationwas completed). Sheean et al. (2014) have previously
shown that MAPK/ERK activation in SCs during development
Figure 6. MAPK/ERK activation does not affect reinnervation of the gastrocnemius muscle at 4 weeks postinjury. Muscle
innervation has been calculated as the number of reinnervated neuromuscular junctions. Gastrocnemius muscle sections of 100
m were stained for a-bungarotoxin (-BTX) as a marker of the postsynaptic NMJ, and for synaptic vesicle protein 2 (SV2) and
neurofilament (2H3) antibodies for presynaptic terminal markers. n 3 mice/group. No significant difference in two-tailed
unpaired t test. Scale bar, 10m. Error bars indicate SEM.
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induced continuous myelination and rescued the myelination
deficit caused by ablation of Shp2 and ErbB3, two signaling mol-
ecules essential for myelination. Given the developmental effects
of MAPK/ERK activation, we hypothesized that it may promote
remyelination. Although remyelination is relatively efficient in
the PNS, there are lasting morphological alterations in remyeli-
nated axons after nerve injury, including an increase in the g-ratio
and shorter internodal length (Beuche and Friede, 1985). How-
ever, we found that MAPK/ERK activation in SCs leads to
impaired peripheral nerve repair, profoundly affecting both
nonmyelinating and myelinating SCs, axon regeneration, and
functional recovery.
Before studying the role of MAPK/ERK in nerve repair, we
confirmed that the sustained induction of the pathway did not
interfere with myelin stability in uninjured adult nerve over this
time course. In contrast to SCs, sustained activation of ERK1/2 in
oligodendrocytes of adult mice had already increased myelin
thickness at 21 d after activation (Jeffries
et al., 2016), although a direct comparison
of the degree of ERK activation achieved
by this allele in oligodendrocytes versus
SCs has not been undertaken. During
WD, the first step of nerve regeneration
after injury, we found a higher inflamma-
tory response in the form of increased
macrophage recruitment and an in-
creased myelin clearance in mutants (Fig.
2A–D). This was in line with the findings
of previous studies showing that the
MAPK/ERK pathway is directly involved
in WD and p-ERK is induced in SCs fol-
lowing injury (Harrisingh et al., 2004; Na-
poli et al., 2012). Napoli et al. (2012)
showed that a transient and strong acti-
vation of the Raf/MEK/ERK pathway
was able to induce a recruitment of inflam-
matory cells (macrophages, mast cells,
neutrophils, and T cells) even in the ab-
sence of injury. SCs andmacrophages par-
ticipate in myelin phagocytosis following
injury and may be contributing to the
increased myelin clearance we observed
after MAPK/ERK activation (Gomez-
Sanchez et al., 2015).
Following the initial phase of WD,
axons begin to regenerate, re-establishing
their close relationship with SCs, which
provide critical guidance and growth factors
for axons.TheSCs thenredifferentiate andre-
myelinate axons (DeFrancesco-Lisowitz et al.,
2015). Ultimately, axons will reinnervate
their targets, leading to restoration of sen-
sorimotor function, although the degree
of recovery is highly dependent on factors
such as type and duration of injury (He et
al., 2014). MEK1DD mutant mice demon-
strated delayed recovery of motor function
compared with controls. An unexpected
finding was that mutants showed a more
rapid recovery of sensory response to pin-
prick application to the paw than control
littermates (Fig. 3E), although the two
groups did not differ at the end point of
4 weeks. This contrasted with the fact that we noted reduced
intraepidermal nerve fiber density in MEK1DD mutants at 3
weeks postinjury (i.e., at a time point when a clear behavioral
difference was observed). This is likely to be due to the fact that
mechanical pain thresholds are well known to be reduced by
inflammatory mediators, which cause a sensitization of these af-
ferents and therefore do not simply reflect the number of sensory
terminals (Petho and Reeh, 2012).
Given these differences in functional recovery, we investigated
morphological changes in both myelinating and nonmyelinating
SCs inMEK1DDmutant mice. MAPK/ERK induction in adult SCs
induced an enlargement of the nerve area, resulting in a reduced
axonal packing as already shown during development (Sheean et
al., 2014; Ishii et al., 2016). However, MAPK/ERK induction did
not enhance myelin thickness in regenerating myelinated fibers
as it does during development (Sheean et al., 2014; Ishii et al.,
2016). In fact, 1 month after injury, we found deficits in myelin
Figure 7. MAPK/ERK induction disrupts Remak bundle formation and small-fiber reinnervation after injury. A, Electronmicro-
graph showing disruption of Remak bundle formation with decreased C-fiber numbers per Remak bundle. Arrows show Remak
bundles in controls and mutants. Visible formation of elongated and supernumerary SCs failing to assemble into normal Remak
bundles (arrowhead). Scale bar, 5m. B, Photomicrographs of transverse sections of ipsilateral skin biopsy specimens stained
with PGP9.5. Quantification of epidermal reinnervation, in IENF per millimeter, showed a decrease in mutant mice. n 3 mice/
group. Arrows point to nerve fibers crossing the epidermis. *p 0.05, two-tailed unpaired t test. Scale bar, 15m. Error bars
indicate SEM.
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compaction and other abnormalities such as recurrent myelin
loops and infoldings. Similar myelin defects were found as a con-
sequence of MAPK/ERK activation in SCs following MAPK/ERK
induction in the postnatal period (Sheean et al., 2014; Ishii et al.,
2016). Nerve injury seems to accelerate myelin abnormalities as-
sociated with p-ERK activation since in the context of regenera-
tion they are abundant already 30 d after injury.
There are differences in the regulation of developmental my-
elination and remyelination. For example, during development
Neuregulin-1 signaling is essential for the initiation of myelina-
tion (Garratt et al., 2000; Taveggia et al., 2005; Birchmeier andNave,
2008; Birchmeier and Bennett, 2016), whereas during nerve repair
Neuregulin-1 determines the rate of remyelination (Fricker et al.,
2011). Neuregulin-1 is dispensable at later stages of repair and, in
particular, does not determine myelination fate (Fricker et al.,
2013). The MAPK/ERK pathway is activated by Neuregulin-1
and during development promotes myelination, but excess acti-
vation of MAPK/ERK by Neuregulin-1 can inhibit myelination
in vitro (Syed et al., 2010). In the context of animal models of
Charcot-Marie-Tooth (CMT) disease, the type I isoform of Neu-
regulin 1 helps to restore the imbalance between MAPK/ERK and
phosphoinositide-3 kinase–AKT signaling pathways and promotes
SC differentiation and axonal survival (Fledrich et al., 2014).
A further unexpected finding inMEK1DDmutant mice was a
loss of appositions between the abaxonal myelin surface and the
SC plasma membrane (Fig. 5A). Appositions in myelinating SCs
are generated by the formation of the so-called PDG complex
which is composed of periaxin, DRP2, and dystroglycan (Gil-
lespie et al., 1994, 2000; Sherman et al., 2001). These appositions
define the border of Cajal bands, which are cytoplasmic channels
first described by Ramon y Cajal (1912) and contain microtu-
bules that may serve a nutritive function (Court et al., 2004). We
found that DRP2 expression was decreased in mutants, whereas
periaxin levels were unchanged (Fig. 5C). To our knowledge, this
is the first evidence of a link among activation of theMAPK/ERK
pathway, DRP2 loss, and Cajal band disruption. Microtubule-
based transport in Cajal bands is used to incorporate newmyelin,
and gene ablation studies of periaxin or DRP2 suggest that the
PDGcomplex stabilizes and limits radial growthofmyelin (Aingeret
al., 1997; Carson et al., 1997; Sherman and Brophy, 2005). The re-
duction in the number of Cajal bands and DRP2 expression could
therefore have relevance to the aberrant myelin we found in
MEK1DDmutants. We also found a decrease in internodal length,
suggesting impaired SC elongation inMEK1DDmutants (Fig. 5D).
This reduction in internodal length is not necessarily caused by a
change in the PDG complex, given that internodal length is not
changed in SCs lacking DRP2. However, periaxin loss results in a
shorter internodal length, indicating that periaxin can have DRP2-
independent functions (Sherman et al., 2012).
MAPK/ERK activation in SCs resulted in dramatic changes in
small-fiber regeneration. Activation of MAPK/ERK led to disrup-
tion of Remak bundle formation. In particular, we noted elongated
processesof thenonmyelinatingSCsandasignificantdecrease in the
number of unmyelinated axons per Remak bundle. These changes
were associatedwithdeficits in reinnervationof cutaneous targets by
unmyelinated axons. Previous literature has focused on the effect of
theMAPK/ERK pathway inmyelinating but not in nonmyelinat-
ing glia (Ishii et al., 2013; Sheean et al., 2014). However, similar
abnormalities in nonmyelinating axons have been described in
animal models of the hereditary neuropathies CMT1A and
CMT4C (Robertson et al., 2002; Houlden et al., 2009). Interest-
ingly, activated MEK/ERK has been reported in such models be-
fore axonal damage (Kohl et al., 2010; Fledrich et al., 2014).
Neurofibromin (NF1) is a Ras-GTPase, which negatively reg-
ulates Ras signaling, and Schwann cells deficient in NF1 develop
dysregulated ERK signaling (Harrisingh and Lloyd, 2004; Jessen
et al., 2013). Interestingly, analysis of the peripheral nerves of
mice in which NF1 is deficient within SCs also demonstrate ab-
normalities of Remak bundles, including a reduced number of
axons per Remak bundle and elongated SC processes (Zhu et al.,
2002; Zheng et al., 2008; Mayes et al., 2011).
Schwann cell processes have been shown to guide regenerat-
ing axons, and it is possible that the impaired regeneration of
unmyelinated axons that we observed is due to deficient physical
interaction between axons and the elongated SC processes (Son
andThompson, 1995;Ho¨ke et al., 2006; Jessen andMirsky, 2016). It
is now recognized that the activation of a transcriptional repair
program in SCs is a critical determinant of the success of axon
regeneration (Painter et al., 2014; Jessen and Mirsky, 2016;
Mindos et al., 2017). It is possible that uncoordinated MAPK
activation leads to reduced trophic factor production by nonmy-
elinating SCs, leading to reduced reinnervation by sensory fibers.
Furthermore, the basal membranemight not be correctly formed
by nonmyelinating SCs, a further determinant of successful rein-
nervation (Frostick et al., 1998; Toy and Namgung, 2013).
In summary, we have investigated the effects of MAPK/ERK in-
duction in adult SCs on the regenerative response to nerve injury. At
early time points, this activation produced an increased inflamma-
tory response and a faster myelin clearance. Despite our initial
hypothesis that MAPK/ERK activation in SCs may promote re-
myelination, it was actually detrimental to functional nerve re-
pair. MAPK/ERK induction had no effect on myelin thickness
but did result in higher rates of myelin decompaction, a reduced
number of Cajal bands, and decreased internodal length.We also
noted abnormal Remak bundle structures with elongated SC pro-
cesses, reducednumber ofC-fibers perRemakbundle, and reduced
reinnervation by sensory fibers. Persistent activation of MAPK/
ERK in SCs is deleterious for nerve repair; however, we cannot
exclude the possibility that transient p-ERK activation (which we
are unable to achieve using this model) could have positive effects,
for instance through enhancedmyelin clearance in the early phaseof
the injury response. These findings emphasize the differences in the
signaling processes that controlmyelin development and repair and
the importance of axoglial interactions in coordinating effective
axon regeneration.
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